Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

• Main Authors: A. Spadaro (Author), A. Scarno (Author), A. Carboni (Author), F.M. Perrotta (Author), C. Catalano (Author), E. Lubrano (Author), G. Valesini (Author)
• Format: Book
• Published: PAGEPress Publications, 2013-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In axial spondyloarthritis (SpA), the efficacy of certolizumab pegol (CZP), a novel pegylated anti-tumor necrosis factor alpha drug has not been investigated. We report that CZP showed a rapid effectiveness, assessed clinically and by magnetic resonance imaging, in a patient with a non-radiographic...